World experts developed a ‘road map’ for the treatment of wet age-related macular degeneration (AMD) at an invitation-only summit, held in Sydney last week.
The one-day summit, convened by the Macular Degeneration Foundation and the US-based Angiogenesis Foundation, brought together 18 world experts in angiogenesis and AMD including researchers, clinicians, scientists, and advocates to share key perspectives and discuss strategies for improving the advocacy, treatment, and vision outcomes for AMD.
Similar summits have been held in Bogota, Colombia (in March this year) and Berlin, Germany (in November 2011).
A key outcome of this landmark summit will be a major report for the future management of wet AMD in Australia, scheduled for release in October.
A key outcome of this landmark summit will be a major report for the future management of wet AMD in Australia, scheduled for release in October…
AMD is the leading cause of blindness and vision loss in Australia. Angiogenesis in the eye results in wet AMD and is characterised by growth and leaking of abnormal blood vessels under the macula. Wet AMD is a chronic disease requiring lifetime treatment.
President of the Angiogenesis Foundation, Dr. William Li said Australia was a world leader in the management and treatment of AMD.
“Restoring the body’s natural control of angiogenesis (blood vessel growth) is a new, comprehensive approach to fighting disease. We have taken the leanings of angiogenesis to develop a global campaign that unites the efforts of all countries to improve the outcomes for wet AMD,” he said.
For more information on the summit phone the MD Foundation on (AUS) 1800 111 709.